Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism

Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-Ile347 polymorphism

US Patent 8420321 · Granted Apr 16, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mutations of the parkin gene, compositions, methods and uses2017
Pyridine derivatives and their use in the treatment of conditions associated wit2016
Pyrazole derivatives and their use as LPAR5 antagonists2016
Benzo[1,3]dioxine derivatives and their use as LPAR5 antagonists2015
Mutations of the parkin gene2014
Methods for determining sodium-proton-exchanger ligand efficiency2013
EGLN2 variants and use thereof in preventing or treating thromboembolic disorder2012
EGLN2 variants and use thereof in preventing or treating thromboembolic disorder2012
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous2012
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous2012
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous2012
Association of EDG5 polymorphism V286A with type II diabetes mellitus and venous2012